Status:
COMPLETED
Behavioral Economics Trial To Enhance Regulation of Blood Pressure (BETTER-BP)
Lead Sponsor:
NYU Langone Health
Collaborating Sponsors:
National Heart, Lung, and Blood Institute (NHLBI)
Conditions:
High Blood Pressure
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
BETTER-BP (Behavioral Economics Trial To Enhance Regulation of Blood Pressure) is a phase II, single-center, prospective, pragmatic randomized clinical trial within the New York City Health and Hospit...
Eligibility Criteria
Inclusion
- A diagnosis of hypertension.
- An active prescription for ≥1 antihypertensive medication (any of the following classes: thiazide diuretic, ACE inhibitor, angiotensin receptor blocker, beta blocker, calcium channel blocker, centrally acting alpha agonist, direct vasodilator).
- 1 ambulatory systolic blood pressure ≥140 mmHg (on therapy).
- Suboptimal adherence (self-report).
Exclusion
- Incarcerated
- Pregnant
- Unable to use study software (Way To Health) in English or Spanish
- Unable/unwilling to consent
- Clear barrier to technology use (e.g. visual or hearing impairment)
- Projected life expectancy \<12 months
Key Trial Info
Start Date :
July 14 2020
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
September 12 2025
Estimated Enrollment :
401 Patients enrolled
Trial Details
Trial ID
NCT04114669
Start Date
July 14 2020
End Date
September 12 2025
Last Update
December 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
NYU Langone Health
New York, New York, United States, 10016